Connecting Youth and Young Adults to Optimize Antiretroviral Therapy Adherence (YouTHrive): Protocol for a Randomized Controlled Trial

JMIR Research Protocols
Keith Joseph HorvathK Rivet Amico

Abstract

Despite intensive efforts to engage people living with HIV in the United States, less than half of the youth aged 13 to 24 years achieve viral suppression. There is a clear and continued need for innovative behavioral programs that support optimizing adherence among young persons with HIV. There are 3 phases of this project. Phase 1 involves conducting focus groups to obtain feedback from youth about an existing technology-based antiretroviral therapy (ART) adherence intervention. Phase 2 will be used to conduct beta testing with youth to refine and finalize the YouTHrive (YT) intervention. Phase 3 is a randomized controlled trial (RCT) to test the efficacy of the YT intervention among youth living with HIV (YLWH). In phase 1, we will conduct 6 focus groups with approximately 8 youths (aged 15-19 years) and young adults (aged 20-24 years), each in 3 US cities to obtain (1) feedback from YLWH about the look and feel and content of an existing adult-focused Web-based ART adherence intervention and (2) suggestions for adapting the intervention for YLWH similar to themselves. Phase 2 will involve updating the existing intervention to include features and functionality recommended by YLWH in phase 1; it will conclude with beta testi...Continue Reading

References

Jan 1, 1989·Social Science & Medicine·M J Stewart
Feb 11, 1999·Journal of Clinical Epidemiology·W N KernanR I Horwitz
Aug 15, 2003·Journal of Personality and Social Psychology·James J Gross, Oliver P John
Aug 19, 2003·Journal of Behavioral Medicine·Seth C KalichmanKari DiFonzo
Nov 17, 2005·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Lynae A Darbes, Megan A Lewis
Mar 30, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Fabrizio StaraceJeffrey D Fisher
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Jan 11, 2007·Journal of Medical Internet Research·Cameron D Norman, Harvey A Skinner
Jul 4, 2007·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Jane M SimoniBu Huang
Aug 30, 2008·Journal of Affective Disorders·Kurt KroenkeAli H Mokdad
Aug 25, 2009·Patient Education and Counseling·Chandra Y Osborn, Leonard E Egede
Nov 17, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jane M SimoniThomas M Hooton
Jun 25, 2010·The Journal of School Health·Mohsen BazarganDavid W Hindman
Jun 24, 2011·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Sulachni ChandwaniLawrence D'Angelo
Mar 1, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Timothy F PageMark Williams
Aug 28, 2012·Current HIV/AIDS Reports·Jennifer A Pellowski, Seth C Kalichman
Sep 5, 2012·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Theresa S BetancourtNathan Hansen
Dec 19, 2012·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Misheck NdebeleMichael Greyling
Jan 8, 2013·Journal of Medical Internet Research·Kathryn E MuessigLisa B Hightow-Weidman
Jan 10, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Eric G BenotschSheana S Bull
Mar 5, 2013·AIDS and Behavior·Valerie A EarnshawMichael M Copenhaver
Apr 10, 2013·AIDS Patient Care and STDs·Kathryn E MuessigLisa B Hightow-Weidman
Jun 21, 2013·Journal of the International AIDS Society·Claude A Mellins, Kathleen M Malee
Jan 5, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ann E KurthKing K Holmes
Jan 23, 2014·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Elizabeth A HahnUNKNOWN PROMIS Cooperative Group
Feb 15, 2014·American Journal of Public Health·Michele Peake AndrasikDaniel Eckstein
Mar 8, 2014·AIDS Patient Care and STDs·Brian C Zanoni, Kenneth H Mayer
Sep 5, 2014·AIDS and Behavior·Anna GaysynskyStephen Arpadi
Jan 30, 2015·Current HIV/AIDS Reports·Kathryn E MuessigLisa B Hightow-Weidman
Sep 20, 2015·Current HIV/AIDS Reports·Lisa B Hightow-WeidmanSara LeGrand
Mar 10, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sarah Shaw, K Rivet Amico
Oct 21, 2016·AIDS and Behavior·Ira B WilsonWilliam H Rogers
Oct 18, 2016·Drug and Alcohol Dependence·Kristi E GamarelUNKNOWN Adolescent Medicine Trials Network for HIV/AIDS Intervention
Dec 17, 2016·AIDS and Behavior·Kristi E GamarelUNKNOWN Adolescent Medicine Trials Network for HIV/AIDS Intervention
Jun 16, 2017·Current Opinion in HIV and AIDS·José A BauermeisterLisa B Hightow-Weidman
Jun 24, 2017·Current Opinion in HIV and AIDS·Kathryn E MuessigLisa B Hightow-Weidman
Nov 29, 2017·Sexually Transmitted Infections·Kristi E GamarelUNKNOWN Adolescent Medicine Trials Network for HIV/AIDS Intervention
Feb 6, 2018·Current Opinion in HIV and AIDS·Michael Evangeli

❮ Previous
Next ❯

Citations

May 9, 2021·BMC Infectious Diseases·Talitha Crowley, Anke Rohwer

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw

Clinical Trials Mentioned

NCT03149757

Software Mentioned

Thrive
YouTHrive
YT
SAS
SurveyGizmo
TWM
Grindr
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.